Table 1.
Univariate analyses between CTCs and clinicopathological factors (n=172).
| Variables | N (%) | CTCs | P | M-CTC | P | ||
|---|---|---|---|---|---|---|---|
| ≥3 | <3 | ≥1 | 0 | ||||
| All patients | 172 (100.0) | 136 (79.1) | 36 (20.9) | 120 (69.8) | 52 (30.2) | ||
| Gender | |||||||
| Male | 107 (65.1) | 84 (78.5) | 23 (24.5) | 0.815 | 77 (69.6) | 30 (30.4) | 0.421 |
| Female | 65 (34.9) | 52 (80.0) | 13 (20.0) | 43 (70.0) | 22 (30.0) | ||
| Depth of invasion | |||||||
| T1–T3 | 118 (68.6) | 90 (76.3) | 28 (23.7) | 0.182 | 82 (69.5) | 36 (30.5) | 0.907 |
| T4 | 54 (31.4) | 46 (85.2) | 8 (14.8) | 38 (70.4) | 16 (29.6) | ||
| Lymphatic metastasis | |||||||
| No | 82 (47.7) | 64 (78.0) | 18 (22.0) | 0.753 | 52 (63.4) | 30 (36.6) | 0.083 |
| Yes | 90 (52.3) | 72 (80.0) | 18 (20.0) | 68 (75.6) | 22 (24.4) | ||
| Distant metastasis | |||||||
| No | 128 (74.4) | 101 (78.9) | 27 (21.1) | 0.928 | 88 (68.8) | 40 (31.2) | 0.620 |
| Yes | 44 (25.6) | 35 (79.5) | 9 (20.5) | 32 (72.7) | 12 (27.3) | ||
| TNM stage | |||||||
| I+II | 65 (37.8) | 49 (75.4) | 16 (24.6) | 0.354 | 41 (63.1) | 24 (36.9) | 0.136 |
| III+IV | 107 (62.2) | 87 (81.3) | 20 (18.7) | 79 (73.8) | 28 (26.2) | ||